Postmus PE - Search Results

1

Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.

Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS. Hoekstra CJ, et al. Among authors: postmus pe. J Clin Oncol. 2005 Nov 20;23(33):8362-70. doi: 10.1200/JCO.2005.01.1189. J Clin Oncol. 2005. PMID: 16293866 Clinical Trial.

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Among authors: postmus pe. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Among authors: postmus pe. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

4

Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.

Postmus PE, Gietema JA, Damsma O, Biesma B, Limburg PC, Vellenga E, de Vries EG. Postmus PE, et al. J Clin Oncol. 1992 Jul;10(7):1131-40. doi: 10.1200/JCO.1992.10.7.1131. J Clin Oncol. 1992. PMID: 1318953

5

Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.

Postmus PE, Smit EF, Berendsen HH, Haaxma-Reiche H. Postmus PE, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):17-23. Semin Oncol. 1992. PMID: 1329219 Clinical Trial.

6

Phase I study of oral teniposide (VM-26).

Smit EF, Ousterhuis BE, Berendsen HH, Sleijfer DT, Postmus PE. Smit EF, et al. Among authors: postmus pe. Semin Oncol. 1992 Apr;19(2 Suppl 6):35-9. Semin Oncol. 1992. PMID: 1329226

7

Treatment of brain metastases of small cell lung cancer with teniposide.

Postmus PE, Smit EF, Berendsen HH, Sleijfer DT, Haaxma-Reiche H. Postmus PE, et al. Semin Oncol. 1992 Apr;19(2 Suppl 6):89-94. Semin Oncol. 1992. PMID: 1329230

8

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Among authors: postmus pe. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

9

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

Biesma B, Willemse PH, Mulder NH, Verschueren RC, Kema IP, de Bruijn HW, Postmus PE, Sleijfer DT, de Vries EG. Biesma B, et al. Among authors: postmus pe. Br J Cancer. 1992 Nov;66(5):850-5. doi: 10.1038/bjc.1992.372. Br J Cancer. 1992. PMID: 1384643 Free PMC article. Clinical Trial.

10

Limitations of the fast green assay for chemosensitivity testing in human lung cancer.

Smit EF, de Vries EG, Meijer C, Mulder NH, Postmus PE. Smit EF, et al. Among authors: postmus pe. Chest. 1991 Nov;100(5):1358-63. doi: 10.1378/chest.100.5.1358. Chest. 1991. PMID: 1657540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

534 results

Search Page